Print

THYMOGEN AMPOULES 10 - for intramuscular injection

Immunostimulating preparation.

Form release: 5 ampules of 1 ml
With shipment: STANDARD INTERNATIONAL SHIPPING: 25,00 €
Base price 30,00 €
30,00 €
Discount
Description

THYMOGEN® has a regulating effect on the reactions of cellular, humoral immunity and nonspecific resistance of the organism. Stimulates the processes of regeneration in case of their oppression. Improves the course of cellular metabolic processes. It enhances the expression of differentiation receptors on lymphocytes, normalizes the number of T-helpers, cytotoxic T-lymphocytes and their ratio in patients with various immunodeficiency states.

The drug quickly enters the systemic circulation after intranasal administration. Alpha-glutamyl-tryptophan sodium under the influence of peptidases is cleaved into L-glutamic acid and L-tryptophan, which are involved in peptide synthesis in the body.

Composition of the preparation:

Thymogen was developed by a team of Leningrad and Moscow scientists for the treatment of immunodeficiency states. The drug was approved for medical use in 1990.

After a century and a half, peptide bioregulators have taken their place among medicines used in the treatment of a wide range of human diseases. Among them are peptide thymomimetics - drugs that have the properties of the thymus hormone and at the same time are not its fragments.

The active substance of Thymogen® is the monosodium salt of L-α-glutamyl-L-tryptophan. It is a synthetic dipeptide consisting of amino acid residues - glutamine and tryptophan. It is identical to a natural compound isolated by chromatography from an extract of the thymus (thymus gland) - an organ in which maturation, differentiation and immunological "training" of T cells of the immune system take place. Its international non-proprietary name (INN) is Oglufanidum (oglufanid). Alpha-glutamyl-tryptophan stimulates cellular factors of immunogenesis, proliferation and differentiation of T-lymphocyte precursors into mature immunocompetent cells, normalizes the ratio of T-helpers / T-suppressors, increases the concentration of cyclic adenosine monophosphate in T-lymphocyte precursors. Strengthens nonspecific resistance of the organism, promotes activation of phagocytic functions of neutrophils and monocytes / macrophages; stimulates interferonogenesis and natural killer cell function (in low doses). Possesses anti-mediator properties. Highly effective for immunodeficiencies of the T-suppressor type.

Indications for use:

The main indication for the use of Thymogen® is a secondary immunodeficiency state. This condition accompanies most infections, injuries, acute and chronic infectious and inflammatory diseases, autoimmune diseases, acute and chronic exposure to ionizing radiation and toxic xenobiotics. Since this condition develops in a variety of diseases, the effective dosage form of the Thymogen® drug and the tactics of its use are largely determined by the specific type of pathological process.

The main areas of application of various dosage forms of the drug Thymogen®:

In combination with etiotropic agents, Thymogen® promotes faster and more complete recovery of the patient, reduces the risk of chronic diseases and complications.

Usage THYMOGEN AMPOULES for intramuscular injection :

In the complex therapy of acute and chronic viral and bacterial diseases, accompanied by a decrease in immunity:

Ingredients:

Solution for intramuscular injection of 100 μg / ml.
1 ml of the drug contains: active substance: sodium alpha-glutamyl-tryptophan (Thymogen® sodium) 100 μg (in terms of alpha-glutamyl-tryptophan), excipients: sodium chloride 9000 μg, water for injection up to 1 ml.

Dosage:

Intramuscularly 1 time per day.
Adults and children from 14 years old - 100 mcg (300-1000 mcg per course),
children from 6 months to 1 year old - 10 mcg; from 1 year to 3 years old - 10-20 mcg; from 4 to 6 years old - 20-30 mcg; from 7 to 14 years old - 50 mcg.
The duration of the course of treatment is from 3 to 10 days.
A repeated course is possible no earlier than 1 month later. During the year, it is possible to conduct 4 courses.

Adverse reactions or complications:

It has been clinically proven that Thymogen® is absolutely safe, non-toxic, non-allergenic, embryotoxic and teratogenic.

Over the 25-year period of using the drug not a single case of any adverse reactions or complications has been reported. Thymogen® is contraindicated only in case of individual intolerance. However, before using any medications to increase and strengthen immunity, you should consult your doctor.

Distinctive features of all forms of the drug Thymogen® are high therapeutic efficacy with the complete absence of side effects and withdrawal symptoms.

Contraindications:

Hypersensitivity to drug components. Children up to age 6 months.

Form release:

Solution for intramuscular injection of 100 μg/ml, 1 ml in ampoules of colorless glass with a pinch and a break ring, or with a pinch, a notch and a dot.
5 ampoules in a blister strip made of polyvinyl chloride film and aluminum foil or without foil.
1 or 2 blister packs (with or without foil) together with instructions for use in a cardboard box. 

100%

Guaranteed authenticity and quality:

100% Original from  CYTOMED (Russian Federation)

Development and production:

CYTOMED (Russian Federation)

St. Petersburg Institute of Bioregulation and Gerontology

cytomed gerontology logo

 

HEPATAMIN - HEPATIC CYTAMINVENAPEPT (Policosanol) - blood vessels peptide IPH AVN
Back to: Peptide therapy